← All trials
NCT01198665
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2010
- Primary completion
- Dec 1, 2014
- Completion date
- Dec 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 46
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Sungkyunkwan UniversityLead sponsor
- Sungkyunkwan UniversityOverall official - principal investigator
- Sungkyunkwan UniversityReponsible party - principal investigator
- Yonsei UniversityCollaborator
- National Cancer Center, KoreaCollaborator
- Korea Cancer Center HospitalCollaborator
- University of UlsanCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.